Skip to main content
. 2021 Apr 8;11(4):945. doi: 10.3390/nano11040945

Figure 3.

Figure 3

Characterization by PXRD (A), porosimetry (B), and Zeta potential (C) of the particles before and after drug loading and/or surface functionalization (black: simulated PXRD patterns for MIL-100 (Al); blue: empty nanoMOFs; green: nanoMOFs coated with CD-CO; purple: nanoMOFs loaded with DOX at TDL of 10%; orange: DOX at TDL of 20%; red: DOX at TDL of 50%; red dashed line: nanoMOFs loaded with DOX at TDL of 50% and coated with CD-CO).